Application Of Interferon Modulators To Overcome Partial Resistance Of Human Ovarian Cancers To Vsv Gp Oncolytic Viral Therapy
interferon modulatorsovarian cancer treatmentVSV oncolytic therapycancer drug resistanceviral immunotherapy
This research investigates the strategic application of interferon modulators to address and overcome partial resistance observed in human ovarian cancers to VSV GP oncolytic viral therapy. By modulating the immune response, this approach seeks to enhance the efficacy of viral therapy, offering a promising new strategy for improving patient outcomes in challenging ovarian cancer cases.